Merck & Co., Inc. (NYSE: MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted the company’s strategic planning for when Keytruda loses patent protection ...
This degree of success can become a double-edged sword, though. While the drug has thrived since its first approval back in ...
With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results